Drug reference
laninamivir octanoate
Investigational Antiviral agent (neuraminidase inhibitor)
Investigational Antiviral agent (neuraminidase inhibitor)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Laninamivir octanoate inhibits the neuraminidase of influenza A and B viruses.
Related guidelines
Other Unclassified drugs
Ask House about laninamivir octanoate
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Harrison 22e·Updated: 2026-05-10